Correlation Between Centessa Pharmaceuticals and SPENN Technology

Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and SPENN Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and SPENN Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and SPENN Technology AS, you can compare the effects of market volatilities on Centessa Pharmaceuticals and SPENN Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of SPENN Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and SPENN Technology.

Diversification Opportunities for Centessa Pharmaceuticals and SPENN Technology

0.0

Correlation Coefficient

Centessa Pharmaceuticals  SPENN Technology

Pay attention - limited upside

The 3 months correlation between Centessa and SPENN is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and SPENN Technology AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SPENN Technology and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with SPENN Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SPENN Technology has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and SPENN Technology go up and down completely randomly.

Pair Corralation between Centessa Pharmaceuticals and SPENN Technology

If you would invest  1,710  in Centessa Pharmaceuticals PLC on September 26, 2024 and sell it today you would lose (20.00) from holding Centessa Pharmaceuticals PLC or give up 1.17% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	95.45%
Values	Daily Returns

Centessa Pharmaceuticals PLC  vs.  SPENN Technology AS

Centessa Pharmaceuticals

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Centessa Pharmaceuticals PLC are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Centessa Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

SPENN Technology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days SPENN Technology AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, SPENN Technology is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Centessa Pharmaceuticals and SPENN Technology

The main advantage of trading using opposite Centessa Pharmaceuticals and SPENN Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, SPENN Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SPENN Technology will offset losses from the drop in SPENN Technology's long position.

The idea behind Centessa Pharmaceuticals PLC and SPENN Technology AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.